DIVISLAB.NS Divi's Laboratories Limited
INR·Price 6719.00·Mkt cap 1.78TComputed from the latest reported financials and the current market price.
Who's the real player?
A genuine play on this theme — most of its business sits right here.
Is the business healthy?
Shaky fundamentals — weak cash generation or a stretched balance sheet. Tread carefully.
- ⚠Weak FCF conversion (<50% of net income turns into free cash)
- Strong growth quality
- Healthy balance sheet
- Positive accrual ratio
Are the smart people buying?
No ownership-change data for this stock. The score reflects heavy growth investment (capex) and buybacks, not visible insider buying.
- Promoter or insider stake at 52.02%
- Insider net buys of 12,963,053
- Capex growth of 75.24%
- Strong ownership concentration
What is management saying?
No earnings-call transcript or filings found for this stock.
Is the price right?
Intrinsic value 95.49 vs price 6719.00 — screens expensive on a cash-flow DCF (-98.6% to intrinsic). The base FCF growth assumption of 0% appears conservative, but without knowing the reverse-DCF implied growth, it's unclear if this is believable.
| Intrinsic / share | 95.49 |
| Price | 6719.00 |
| Upside to intrinsic | -98.6% |
| Reverse-DCF implied g | 50.0% |
Base FCF 2.30B · growth 0.0% · discount 12.0% · terminal 5.0%.
Sensitivity — intrinsic value / share
Each cell is the intrinsic value at that growth (across →) and discount rate (down ↓). Center ★ is the base case. Cells green = above price (cheap), red = below (expensive).
| Growth rate → | |||||
|---|---|---|---|---|---|
| Disc ↓ ╲ g | -4% | -2% | 0% | 2% | 4% |
| 10% | 95.51 | 110.49 | 128.12 | 148.82 | 173.11 |
| 11% | 82.64 | 94.84 | 109.13 | 125.86 | 145.42 |
| 12% | 73.33 | 83.55 | ★ 95.49 | 109.4 | 125.62 |
| 13% | 66.26 | 75.01 | 85.19 | 97.02 | 110.76 |
| 14% | 60.69 | 68.3 | 77.12 | 87.34 | 99.18 |
Through the masters' eyes
Each investor's numeric rules, checked against this stock's metrics: exact math, no guesswork. Tap one to see which rules pass, fail, and what to judge yourself.
▶
Passes 2 of 2 of Peter Lynch's numeric checks. Still judge the non-numeric criteria below for yourself.
- Manageable debt (D/E ≤ 1.0) — now 0
- Solid liquidity (current ratio ≥ 1.5) — now 5.43
- A simple business you understand
- Which 'type' it is (fast grower, stalwart, cyclical…)
- A believable growth story
Couldn't check from available data: PEG ≤ 1 (growth cheap vs price) — not available; Earnings growth ≥ 15% — not available
▶
Passes 2 of 2 of Vijay Kedia's numeric checks. Still judge the non-numeric criteria below for yourself.
- ROE ≥ 15% — now 15.3%
- Manageable debt (D/E ≤ 1.0) — now 0
- Ambitious, capable management
- A small company with a large opportunity
- Patience to hold for years
Couldn't check from available data: Strong earnings growth ≥ 20% — not available
▶
Passes 4 of 5 of Warren Buffett's numeric checks. Still judge the non-numeric criteria below for yourself.
- ROE ≥ 15% — now 15.3%
- Net margin ≥ 10% — now 24.3%
- Positive free cash flow — now 2.1%
- Conservative leverage (D/E ≤ 1.0) — now 0
- Trades below intrinsic value (margin of safety ≥ 0) — now -6936.6%
- A business you can understand
- A durable competitive moat
- Honest, capable management
▶
Passes 3 of 4 of Charlie Munger's numeric checks. Still judge the non-numeric criteria below for yourself.
- High returns on capital (ROCE ≥ 15%) — now 16.6%
- ROE ≥ 15% — now 15.3%
- Conservative leverage (D/E ≤ 1.0) — now 0
- Trades below intrinsic value (margin of safety ≥ 0) — now -6936.6%
- A high-quality, understandable business
- A durable moat
- Management of integrity
▶
Passes 3 of 4 of Radhakishan Damani's numeric checks. Still judge the non-numeric criteria below for yourself.
- Very low debt (D/E ≤ 0.5) — now 0
- Consistent revenue (consistency ≥ 80%) — now 92.5%
- Positive net margin — now 24.3%
- High returns on capital (ROCE ≥ 18%) — now 16.6%
- A durable consumer franchise
- Pricing power
- A long runway, bought patiently
▶
Passes 2 of 3 of Rakesh Jhunjhunwala's numeric checks. Still judge the non-numeric criteria below for yourself.
- Net margin ≥ 10% — now 24.3%
- Conservative leverage (D/E ≤ 1.0) — now 0
- ROE ≥ 18% — now 15.3%
- A large, scalable opportunity
- Trustworthy, ambitious management
- Conviction to hold through volatility
Couldn't check from available data: Earnings growth ≥ 15% — not available
▶
Passes 3 of 6 of Benjamin Graham's numeric checks. Still judge the non-numeric criteria below for yourself.
- Strong liquidity (current ratio ≥ 1.5) — now 5.43
- Debt below equity (D/E ≤ 1.0) — now 0
- Financially safe (Altman Z ≥ 3) — now 54.47
- P/E ≤ 15 — now 68.84
- P/B ≤ 1.5 — now 10.55
- Graham number: P/E × P/B ≤ 22.5 — now 726.3
- A long record of stable earnings
- An uninterrupted dividend history
▶
Passes 1 of 2 of Raamdeo Agrawal's numeric checks. Still judge the non-numeric criteria below for yourself.
- Longevity: revenue consistency ≥ 70% — now 92.5%
- Quality: ROCE ≥ 18% — now 16.6%
- Durability of the growth (longevity)
- Quality and honesty of management
Couldn't check from available data: Growth: earnings CAGR ≥ 15% — not available; Price: PEG ≤ 2 — not available
Financial statements (INR)
↗ sourceCash-flow lines highlighted — we trust cash over reported profit.
| Line | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 105.60B | 93.60B | 77.96B | 76.65B | — |
| Operating income | 29.78B | 25.66B | 18.32B | 20.27B | — |
| EBITDA | 38.74B | 33.20B | 25.44B | 27.12B | — |
| Net income | 25.68B | 21.91B | 16.00B | 18.24B | — |
| Operating cash flow | 27.38B | 16.53B | 12.61B | 24.59B | — |
| Capex | -25.20B | -14.38B | -10.03B | -4.73B | — |
| Free cash flow | 2.18B | 2.15B | 2.58B | 19.86B | — |
| Total assets | 200.33B | 169.32B | 154.70B | 144.39B | — |
| Total equity | 167.61B | 149.69B | 135.71B | 127.67B | — |
| Total debt | 70.00M | 40.00M | 30.00M | 40.00M | — |
| Cash & equivalents | 1.28B | 4.15B | 3.63B | 1.70B | — |